Bill Morneau released his fourth Federal Budget in the House of Commons at 4pm today.
Year in Review:
In 2018, the federal budget established an independent Advisory Council on the Implementation of National Pharmacare. Over the past year, the Advisory Council, lead by Dr. Eric Hoskins, released a discussion paper in ... Read More
News & Events
19
Mar2019
14
Mar2019
Each month the pCPA issues an update on the previous month’s negotiation activity. In Table 1 below you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest.... Read More
05
Mar2019
Health Canada and CADTH launch new initiative to provide Early Parallel Scientific Advice
/ CADTH, pCODR, What's New
On February 28, 2019, Health Canada and CADTH, with INESSS participating as an observer, announced a new joint Early Parallel Scientific Advice collaboration. The initiative seeks to provide more timely access to medicines for Canadians. Through this initiative, drug sponsors will obtain advice in parallel from Health Canada and ... Read More
22
Feb2019
CADTH is launching a new Patient and Community Advisory Committee
After talks with patient groups this past fall, CADTH is creating a 12-person advisory committee to discuss the experiences of patients and family caregivers in Canada. They invite nominations for those with extensive experience as a patient or family caregiver in ... Read More
15
Feb2019
The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually at the provincial and territorial levels. Each month the pCPA issues an update on the previous month’s negotiation activity. A file is complete once a Letter of Intent (LOI) is ... Read More
11
Feb2019
In keeping with our continuing efforts to support transparency and share input submissions for public policy consultations, PDCI is hosting responses to a recent CADTH survey that was conducted on behalf of the Provincial/Territorial (P/T) Expensive Drugs for Rare Disease Working Group (EDRD WG). The EDRD WG sought public feedback ... Read More
07
Feb2019
On February 6, 2019, CADTH announced a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer Parallel Scientific Advice to pharmaceutical companies. Participating pharmaceutical companies will receive advice simultaneously from CADTH and NICE to facilitate evidence generation for the Canadian and English markets.
This new opportunity ... Read More
04
Feb2019
Observations on National Pharmacare from John-Paul Dowson, PDCI’s Director of Reimbursement Strategy.
17
Jan2019
The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually at the provincial and territorial levels. Each month the pCPA issues an update on the previous month’s negotiation activity. A file is complete once a Letter of Intent (LOI) is ... Read More
08
Jan2019
The PMPRB has announced the rest of the 2019 meeting dates to the Human Drug Advisory Panel (HDAP)’s calendar for 2019, bringing to the total meetings up to four (4), as per previous years.
HDAP Meeting
Patentee Submission Deadline
Monday, February 25th, 2019
Thursday, November 29th, 2018
Monday, May 27th, ... Read More